Metformin for women who are obese during pregnancy for improving maternal and infant outcomes

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Eames, Amanda J ^a   Grivell, Rosalie M ^a   Deussen, Andrea R ^a   Hague, William ^b   Dodd, Jodie M ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO;

APGAR SCORE; ARTICLE; BIRTH INJURY; BREAST FEEDING; CAUSE OF DEATH; CESAREAN SECTION; DIARRHEA; GENDER; GESTATIONAL AGE; GESTATIONAL WEIGHT GAIN; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INFANT; INSULIN SENSITIVITY; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; MATERNAL DEATH; MATERNAL HYPERTENSION; META ANALYSIS; NAUSEA; OBESITY; PERINATAL DEATH; PERINEUM INJURY; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL INFECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOULDER DYSTOCIA; SYSTEMATIC REVIEW; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; VOMITING;

EID: 84941803269     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010564     Document Type: Article

References (49)

1. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2]
2. Bailey CJ, Turner RC. Metformin. New England Journal of Medicine 1996;334:574-9.
3. Beyerlein A, Schiessl B, Lack N, von Kries R. Associations of gestational weight loss with birth-related outcome: a retrospective cohort study. BJOG: an international journal of obstetrics and gynaecology 2011;118:55-61.
4. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Medical Journal of Australia 2006;184(2):56-9.
5. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996;45:1455-62.
6. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?. American Journal of Obstetrics & Gynecology 2011;204(6):479-87.
7. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics and Gynecology 2004;103:219-24.
8. Cedergren MI. Optimal gestational weight gain for body mass index categories. Obstetrics and Gynecology 2007;110:759-64.
9. Chan A, Scheil W, Scott J, Nguyen A-M, Sage L. Pregnancy Outcome in South Australia. Pregnancy Outcome Unit, SA Health, Government of South Australia, 2009.
10. Chen C-S, He J, Kelly T, Reynolds K, Yang W. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity 2008;32(9):1431.
11. Crane JM, White J, Murphy P. The effect of gestational weight gain by body mass index on maternal and neonatal outcomes. Journal of Obstetrics and Gynaecology Canada 2009;31:28-35.
12. Cusi K, DeFronzo RA. Metformin: a review of its metabolic effects. Diabetes Review 1998;6:89-131.
13. Dodd JM, Grivell RM, Nguyen A-M, Chan A, Robinson JS. Maternal and perinatal health outcomes by body mass index category. Australian and New Zealand Journal of Obstetrics and Gynaecology 2011;51(2):136-40.
14. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. American Journal of Obstetrics and Gynecology 2004;191(3):964-8.
15. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and burden of disease. Lancet 2002;360:1347-60.
16. Furber C, McGowan L, Bower P, Kontopantelis E, Quenby S, Lavender T. Antenatal interventions for reducing weight in obese women for improving pregnancy outcome. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD009334]
17. Galtier-Dereure F, Montpeyroux F, Boulot P, Bringer J, Jaffiol C. Weight excess before pregnancy: complications and cost. International Journal of Obesity and Related Metabolic Disorders 1995;19:443-8.
18. Gilbert C, Valois M, Koren G. Pregnancy outcome after first trimester exposure to metformin: a meta-analysis. Fertility & Sterility 2006;86:658-63.
19. Greenberg AS. Obesity and the role of adipose tissue in inflammation and metabolism. American Journal of Clinical Nutrition 2006;83:461-5.
20. Hawthorne G. Metformin use and diabetic pregnancy. Diabetic Medicine 2006;23(3):223-7.
21. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon, Chandramouli V, et al.Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000;49:2063-9.
23. Institute of Medicine. Weight Gain During Pregnancy: Re-examining the Guidelines. Washington, DC: National Academies Press, 2009.
24. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al.Efficacy and metabolic effects of metformin and troglitazone in type 2 diabetes mellitus. New England Journal of Medicine 1998;338:867-72.
25. Ismail KMK, Issa BG, Jones P, Hanna FW, Indusekhar R. Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD009828]
26. Kiel DW, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women. Obstetrics and Gynecology 2007;110(4):752-8.
27. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Annals of Internal Medicine 2002;137:25-33.
28. Large V, Beylot M. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes 1999;48(6):1251-7.
29. Levri KM, Slaymaker E, Last A, Yeh J, Ference J, D'Amico F, et al.Metformin as treatment for overweight and obese adults: a systematic review. Annals of Family Medicine 2005;3(5):457-61.
30. Lilja AE, Mathieson ER. Polycystic ovary syndrome and metformin in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2006;85:861-8.
31. Lyon CJ. Adiposity, inflammation and atherogenesis. Endocrinology 2003;144:2195-200.
32. McConway MG, Johnson D, Kelly A, Griffen D, Smith J, Wallace AM. Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Annals of Clinical Biochemistry 2000;37:717-23.
33. Nieuwenhuis-Ruifrok AE, Kuchenbecker WKH, Hoek A, Middleton P, Norman RJ. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: a systematic review and meta-analysis. Human Reproduction Update 2009;15(1):57-68.
34. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
35. Oken E, Kleinman KP, Belfort MB. Associations of gestational weight gain with short- and longer-term maternal and child health outcomes. American Journal of Epidemiology 2009;170:173-80.
36. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinologica 1954;16:330-42.
37. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, et al.Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 1994;43:920-8.
38. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology and Metabolism 2003;87(9):4231-7.
39. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
40. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW. Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. International Journal of Obesity and Related Metabolic Disorders 2001;25:1175-82.
41. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obesity Reviews 2001;2:189-97.
42. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese?. Obesity 2008;16(10):2323-30.
43. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378(9805):1778.
44. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH. Obesity, obstetric complications and caesarean delivery rate - a population-based screening study. American Journal of Obstetrics and Gynecology 2004;190:1091-7.
45. Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs 1999;58(Suppl 1):31-9.
46. Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obesity Reviews 2011;12:131-41.
47. WHO. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series. Number 894. Geneva (Switzerland): WHO, 2000.
48. Mathers C, Stevens G, Mascarenhas M. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva (Switzerland): WHO, 2009.
49. Yu CKH, Teoh TG, Robinson S. Obesity in pregnancy. BJOG: an international journal of obstetrics and gynaecology 2006;113:1117-25.